IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 5539 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Next article
  Previous article 
  Table of Contents
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (47 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

In This Article

 Article Access Statistics
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal


Year : 2006  |  Volume : 38  |  Issue : 4  |  Page : 300


Department of Pharmacology, Government Medical College, Amritsar, India

Correspondence Address:
G K Randhawa
Department of Pharmacology, Government Medical College, Amritsar
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

How to cite this article:
Randhawa G K. Reply. Indian J Pharmacol 2006;38:300

How to cite this URL:
Randhawa G K. Reply. Indian J Pharmacol [serial online] 2006 [cited 2023 Oct 2];38:300. Available from: https://www.ijp-online.com/text.asp?2006/38/4/300/27037

I thank D. Badyal for his comments on the article "Orphan Diseases and Drugs" (Ind J Pharmacol 2006; 38: 171-76) are welcome. Most of the issues mentioned have already been covered in the article though in a different perspective. A majority of the references cited in support of the facts by the authors are of 2006 whereas the present article was submitted on 17.8.2005.

1. The definition given in the article is standard (WHO). The variations to definition have been highlighted on page 175 para 1- Orphan vaccines and devices, Orphan Drug Status for non-orphan diseases have also been mentioned.

2. As regards the classification, there is at present no single standard consensus classification and all kinds of classifications cannot be given in a single article. The most befitting classification in accordance with the scope of this article was used in order to avoid any confusion.

3.Solution to ODS related to Third World Countries was given on page 175 'The public -private partnerships for R & D initiatives offers a new and effective way to deal with the medical needs of orphan disease patient.-DNDi'. It is agreed that the industry alone is not responsible for manufacturing less number of drugs with ODS.


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow